Apellis Pharmaceuticals, Inc. · NASDAQ:APLS
Deschatelets Pascal reported 12 trades in Apellis Pharmaceuticals, Inc. shares (Form 4)
Traded May 14, 2026 · Filed May 14, 2026
On May 14, 2026, Deschatelets Pascal (Chief Scientific Officer) reported 12 trades in Apellis Pharmaceuticals, Inc. shares, leaving 0 shares. Filed May 14, 2026 (Form 4).
- Shares
- 1,177,222 shares
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 14, 2026 | Common Stock | Other | 1,177,222 | 0 | Direct | |
| May 14, 2026 | Common Stock | Award | 41,250 | 41,250 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 41,250 | 0 | Direct | |
| May 14, 2026 | Common Stock | Award | 10,030 | 10,030 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 10,030 | 0 | Direct | |
| May 14, 2026 | Common Stock | Award | 12,920 | 12,920 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 12,920 | 0 | Direct | |
| May 14, 2026 | Common Stock | Award | 25,840 | 25,840 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 25,840 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 4,909 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 3,372 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 11,284 | 0 | Direct |
Source
Related
- Apellis Pharmaceuticals, Inc.
- Deschatelets Pascal
- Apellis Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2026
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Form 4 · Dunlop A. Sinclair · May 14, 2026
- Form 4 · Chopas James George · May 14, 2026